A Study to Evaluate the Efficacy and Safety of QL1706 Injection in Patients With Solid Tumors
Clinical trial NCT05171790 · UNKNOWN
Trial details
- NCT number
- NCT05171790
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-11
- Primary completion
- 2021-12-31
- Enrollment
- 419
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.